ONPH — Oncology Pharma Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.61m
- $0.01m
Annual cashflow statement for Oncology Pharma, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2002 March 31st | 2003 March 31st | 2004 March 31st | 2011 June 30th | 2013 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | — | 12 M |
Source: | 10KSB | 10KSB | 10KSB | ARS | |
Standards: | USG | USG | USG | — | — |
Status: | Final | Final | Final | fx Preliminary | Final |
Net Income/Starting Line | -1.95 | -1.52 | -1.56 | — | -0.186 |
Depreciation | |||||
Non-Cash Items | 0.004 | 0.037 | -0.135 | — | 0 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.156 | -0.356 | -0.381 | — | 0.185 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -1.45 | -1.44 | -2 | — | -0.007 |
Capital Expenditures | -0.323 | -0.147 | -0.017 | — | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | 0.002 | 0.133 | — | -0.186 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.323 | -0.145 | 0.116 | — | -0.186 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.633 | 0.001 | 0.546 | — | 0.206 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.14 | -1.59 | -1.34 | — | 0.012 |